Published in Tumori on June 11, 2007
Cardiovascular events and intensity of treatment in polycythemia vera. N Engl J Med (2012) 5.87
Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review). Int J Oncol (2012) 1.81
Increased serum levels of neutrophil gelatinase-associated lipocalin in patients with essential thrombocythemia and polycythemia vera. Leuk Lymphoma (2010) 1.46
The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: a retrospective multicentric GIMEMA experience. Am J Hematol (2011) 1.27
Soil-catalyzed polymerization of phenolics in polluted waters. Water Res (2002) 1.03
The APOE epsilon4 allele increases the risk of impaired spatial working memory in obstructive sleep apnea. Sleep Med (2008) 1.03
High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications. Br J Haematol (2014) 1.00
Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension. Am J Obstet Gynecol (2007) 0.98
A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy. Br J Haematol (2013) 0.97
Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features. Clin Cancer Res (2013) 0.92
Differential levels of soluble endoglin (CD105) in myeloid malignancies. J Cell Physiol (2003) 0.91
The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression. Eur Neuropsychopharmacol (2011) 0.90
Influence of complex variant chromosomal translocations in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors. Acta Oncol (2010) 0.90
Long-term durability of the Hancock II porcine bioprosthesis. J Thorac Cardiovasc Surg (2003) 0.90
Clinical significance of circulating interleukin-23 as a prognostic factor in breast cancer patients. J Cell Biochem (2012) 0.88
Can C4d immunostaining on endomyocardial biopsies be considered a prognostic biomarker in heart transplant recipients? Transplantation (2010) 0.88
Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia. PLoS One (2011) 0.87
Levels of soluble angiogenin in chronic myeloid malignancies: clinical implications. Eur J Haematol (2004) 0.87
The cancer stem cell hypothesis: a guide to potential molecular targets. Cancer Invest (2014) 0.86
Coronary flow velocity pattern and coronary flow reserve by contrast-enhanced transthoracic echocardiography predict long-term outcome in heart transplantation. Circulation (2006) 0.86
Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma. Eur J Haematol (2013) 0.85
Prospective validation of a risk score based on biological markers for predicting progression free survival in Binet stage A chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study. Am J Hematol (2014) 0.85
JAK2 V617F-positive latent essential thrombocythemia and splanchnic vein thrombosis: the role of bone marrow biopsy for the diagnosis of myeloproliferative disease. Acta Haematol (2009) 0.84
Nonlocal effects: relevance for the spontaneous emission rates of quantum emitters coupled to plasmonic structures. Opt Lett (2014) 0.84
Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia. Am J Hematol (2012) 0.84
Human cytomegalovirus-specific T-cell immune reconstitution in preemptively treated heart transplant recipients identifies subjects at critical risk for infection. J Clin Microbiol (2012) 0.84
Endothelial progenitor cells: pathogenetic role and therapeutic perspectives. J Nephrol (2009) 0.84
Intravascular macrophages in cardiac allograft biopsies for diagnosis of early and late antibody-mediated rejection. J Heart Lung Transplant (2013) 0.83
MiRNome expression is deregulated in the peripheral lymphoid compartment of multiple myeloma. Br J Haematol (2014) 0.83
Imatinib mesylate therapy induces reduction in neutrophil gelatinase-associated lipocalin serum levels and increase in leptin concentrations in chronic myeloid leukemia patients in molecular remission. Acta Haematol (2011) 0.83
Oxidative stress in oncohematologic diseases: an update. Expert Rev Hematol (2013) 0.82
Possible role of erythropoietin in the pathogenesis of chronic cor pulmonale. Nephrol Dial Transplant (2005) 0.82
Bisphosphonates induce apoptosis of circulating endothelial cells in multiple myeloma patients and in subjects with bisphosphonate-induced osteonecrosis of the jaws. Acta Haematol (2010) 0.82
Wernicke's encephalopathy after allogeneic stem cell transplantation. Tumori (2007) 0.82
Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors. Eur J Haematol (2010) 0.82
Outcome after pediatric heart transplantation: two decades of a single center experience. Eur J Cardiothorac Surg (2007) 0.82
Role of morphologic parameters on endomyocardial biopsy to detect sub-clinical antibody-mediated rejection in heart transplantation. J Heart Lung Transplant (2011) 0.81
Emerging targeted therapies for castration-resistant prostate cancer. Front Endocrinol (Lausanne) (2012) 0.81
Reduced serum levels of Interleukin 17 in patients with osteonecrosis of the jaw and in multiple myeloma subjects after bisphosphonates administration. Cytokine (2008) 0.81
Epigenetic therapy in myelodysplastic syndromes. Eur J Haematol (2010) 0.80
Decreased plasma levels of IL-33 could contribute to the altered function of Th2 lymphocytes in patients with polycythemia vera and essential thrombocythemia. Cancer Invest (2013) 0.80
Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease. Br J Haematol (2012) 0.80
Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cells. Eur J Haematol (2011) 0.79
Familial B-cell chronic lymphocytic leukemia in a population of patients from Southern Italy. Int J Hematol (2004) 0.79
Cardiac involvement in patients with hematologic malignancies. J Investig Med (2010) 0.79
Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and in two relatives with lymphoproliferative disorders. Acta Haematol (2009) 0.79
ABO-incompatible heart transplantation: crossing the immunological barrier. J Cardiovasc Med (Hagerstown) (2008) 0.79
Increase of novel biomarkers for oxidative stress in patients with plasma cell disorders and in multiple myeloma patients with bone lesions. Inflamm Res (2012) 0.79
Oseltamivir-resistant pandemic (H1N1) 2009 treated with nebulized zanamivir. Emerg Infect Dis (2010) 0.79
Involvement of T2677T multidrug resistance gene polymorphism in Interleukin 22 plasma concentration in B-chronic lymphocytic leukemia patients. Acta Oncol (2011) 0.78
Reduction in IL-33 plasma levels might be involved in T cell dysregulation in chronic lymphocytic leukemia. Acta Haematol (2013) 0.78
Nanoparticles in oncology: the new theragnostic molecules. Anticancer Agents Med Chem (2011) 0.78
Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB1*1501 and HLA-DQB1*0602. Acta Oncol (2011) 0.78
Patients with bisphosphonate-associated osteonecrosis of the jaw have unmodified levels of soluble vascular endothelial growth factor receptor 1. Leuk Lymphoma (2007) 0.78
[Lipid profile in hematologic neoplasms]. Recenti Prog Med (2002) 0.78
Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study. Am J Hematol (2013) 0.78